Your institution may have access to this item. Find your institution then sign in to continue.
Title
Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.
Authors
Kane, Sunanda V; Sumner, Michael; Solomon, Dory; Jenkins, Matthew
Abstract
Patients receiving 5-aminosalicylic acid (5-ASA) require long-term therapy to achieve good outcomes. Persistency (duration of time from initiation to discontinuation of therapy) is therefore an important consideration.
Publication
Digestive diseases and sciences, 2011, Vol 56, Issue 12, p3463